Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H11Cl2NO4 |
Molecular Weight | 328.147 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=C(O)C=C(NCC2=C(O)C(Cl)=CC(Cl)=C2)C=C1
InChI
InChIKey=RTEYSQSXRFVKTJ-UHFFFAOYSA-N
InChI=1S/C14H11Cl2NO4/c15-8-3-7(13(19)11(16)4-8)6-17-9-1-2-10(14(20)21)12(18)5-9/h1-5,17-19H,6H2,(H,20,21)
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: nNOS/PSD-95 interaction Sources: https://www.ncbi.nlm.nih.gov/pubmed/26177569 |
PubMed
Title | Date | PubMed |
---|---|---|
Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions. | 2015 Jul 16 |
|
Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system. | 2015 Jul 29 |
|
ZL006 protects spinal cord neurons against ischemia-induced oxidative stress through AMPK-PGC-1α-Sirt3 pathway. | 2017 Sep |
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1181226-02-7
Created by
admin on Sat Dec 16 19:22:01 GMT 2023 , Edited by admin on Sat Dec 16 19:22:01 GMT 2023
|
PRIMARY | |||
|
245DFR6JM5
Created by
admin on Sat Dec 16 19:22:01 GMT 2023 , Edited by admin on Sat Dec 16 19:22:01 GMT 2023
|
PRIMARY | |||
|
44207238
Created by
admin on Sat Dec 16 19:22:01 GMT 2023 , Edited by admin on Sat Dec 16 19:22:01 GMT 2023
|
PRIMARY |